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9/10/2014

Designing a Research Study
Tim Petersen, PhD

What do you mean- “design” a study?




Studies don’t come in a box
Many things to consider
Decisions to make






None need be prohibitive or scary
But each one matters
Some will even seem automatic (yay!)

“Study design” is just the sum of these
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No study is perfect



So let your goal be “good enough”… and exhale

So what‟s involved?









Settling on your research question/hypothesis
Choosing an overall approach
Deciding which data to gather
And how many subjects you’ll need
Reducing bias with randomization & blinding
Then write the protocol
Keep those pesky rules and expectations in mind
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Time invested up front…


Is time saved / not wasted during:






IRB approval process
data collection
analysis
writing
peer review

The research question
Begin with a basic idea
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Keep an eye out for opportunities










Here we do things this way, but at my old institution we did things
that way
Somebody’s passing comment or odd question
Unresolved questions in literature: review article, intro, discussion
section, etc
Disagreements among colleagues: wanna bet?
Interesting article: tweak it (this is almost always possible!)
New-ish treatment with inexplicable popularity
Planned change to a treatment pathway
They say always/never do XYZ: evidence for Dr. They’s position?

Start informally






Can I reduce the amount of LA used in this block and still
retain effectiveness?
Which grip is best for novices on their first efforts at
mask ventilation?
Does it matter which brand of block needle I use?
Does this drug really reduce intraop blood loss?
What’s the best sedation protocol for this particular set
of pediatric imaging patients?
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Hit the literature

Research
idea

Literature

An example
Starting with outcomes selection
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Compare treatments‟ effect on postop pain


Which treatment better controls postoperative pain?

Moving past “what’s better?”



Formalize the comparison
Consider all salient points of the setting






Which providers?
Which patient population?
What treatments/groups?
What outcome(s)?
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Outcomes


What will you measure?





One primary outcome
A few secondary ones

Surrogate vs. “real” clinical outcomes (it’s a spectrum)



Lab values, etc
Complications, survival, pain-free time, etc

Compare treatments‟ effect on postop pain












Time to first request of pain meds
Time to first report of any sensation
Time to first report of pain
Total opioid consumption, within XX time period
Max pain score in XX time period; resting or dynamic
Patient satisfaction overall, or specifically with pain control
Proportion of patients who ever hit, say, ≥8 on pain scale
Reduction of opioid-related side effects
Etc.
Why did you pick this one?
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Why not just test all of „em?









Problem of multiple comparisons
Shorthand: at 0.05 significance level, we have a 95%
chance of being “right” on a given test
With two tests, the chance of being right twice (no
errors) is just over 90%
Ten: 60%
Twenty: 36% (that’s a 64% chance of ≥1 spurious result!)
So use statistical tests sparingly
Adjustments are available, but they’re harsh

It‟s a balance



Clinical interest
Ease of data collection
Intended knowledge gap to fill



That’s the whole point of this talk
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Clinical significance


Always keep this in mind



I can design a study that will show that donuts increase
the relative risk of thumb cancer by 3%



Who cares?

xkcd.com/892/
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2-tailed vs. 1-tailed


2-tailed analyses






Is there any difference between these treatments?
Null hypothesis: they are equal
The default

1-tailed analyses






We have some solid reason to think that A is better than B
Is that really the case?
Null hypothesis: they are equal, or B is better
Being more specific yields a p-value bonus (p/2)
Less common

4.bp.blogspot.com

www.cliffsnotes.com

10

9/10/2014

Hypothesis/ Research Question


Should be succinct but specific




Primary outcome




We hypothesized that the addition of dexamethasone 8 mg to
ropivacaine-based sciatic nerve block would result in a delay in
patients’ first request for pain medication, as compared to preop IV
administration of the same dose.

Time to first request of pain medication

Secondary outcomes


Total opioid consumption within first 48 hours postop

Selecting the design
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Some of the main types (for us)


When patients are enrolled, and what happens






Prospective
Retrospective
Observational

Comparison: superiority vs. equivalence vs. noninferiority





Are these different/ is one better?
Are they the same (within limits)?
Is this one at least not worse than that one?

Benefits and Costs


Prospective





Retrospective





Randomization
Consent refusals
Ease of data collection
Limited to what’s there

Observational



100% data capture!
Can’t manipulate treatment
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More on Randomization


From a scientific perspective, it’s almost always best


But maybe not logistically



Or maybe it’s just not a good fit for your question



Sometimes you just want to know how often something
happens in the real world



We’ll come back to this

Moving on to the comparison itself…


Superiority



Equivalence



Noninferiority
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Superiority trials


But wait… let’s have a brief tangent

Confidence interval



A statement of probability
Usually a 95% CI








“The difference between the group means was 6.5 units (95% CI 310).”

If we were to do this study many times, 95% of the resulting
CIs would contain the true difference.
If p=0.05, the 95% CI has zero at one end (e.g. 0 – 3 units)
If p > 0.05, it spans 0
If p < 0.05, it does not
The CI for a 1-tailed test only omits 5% (say) at one end
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OK, getting back to it…

Superiority trials




So common they’re the default
Do treatments A and B provide different results on this
outcome?
Hypothesis




Null hypothesis





A is different from B
A and B are equivalent

Hope to get a 95% CI that excludes 0
Can be 2-tailed or 1-tailed
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Equivalence trials





Treatment A is cheaper, easier, etc than treatment B
Are the clinical outcomes any different?
Need an a priori clinically significant idea of “different”: Δ
Hypothesis




Null hypothesis





-Δ < 95% CI for difference < Δ

95% CI contains Δ or –Δ (or both)

Hope to get a 95% CI that fits within ±Δ
Must be 2-tailed

Noninferiority trials



Hybrid of superiority and equivalence; imagine a 1-tailed
equivalence trial
Is treatment A at least not worse than treatment B?





Still need Δ
Hypothesis




Shorthand: A – B ≥ 0

-Δ < 95% CI for difference (which is infinite on this side)

Null hypothesis


95% CI includes –Δ
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95% CI results and trial types
Results: groups’ difference
–Δ

0

Δ

Reject null hypothesis?
Superiority

Equivalence

Noninferiority

-ish

, but…

Data to gather
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So many data…



How do I select from the universe of data?

Where to start?




Age, sex, BMI, etc unless there’s a reason not to
The outcomes of interest (obviously)
So many confounders….






Beware the rabbit hole
Show your groups to be similar enough
Consider excluding problem people

Try to keep data collection simple



Number of sources of info; time investment
Certain data require HIPAA authorization (∴ consent)


Worth it?
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OK, I‟ve decided what data to gather
How many times must I do it? And to whom?

What‟s a power analysis?



Usually, an estimate of the needed sample size
Based on certain knowledge or assumptions









Desired power
Type I error rate: α (the p value threshold)
Expected effect size (for specific outcome!)
Expected variation within groups
The chosen statistical test

Always ask about this; journals and IRB expect it
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Power analysis


Power







Chance of avoiding a Type 2 error: i.e. false negative.
1 – ß (where ß = type 2 error risk)
Usually set at 80%; typically higher with high-benefit studies
“If there’s anything there, will we see it?”

Alpha (significance threshold)




Chance of having a Type I error: i.e. false positive.
Usually set at 0.05; lower with high-risk studies
“Will our result be reliable?”

Power, continued


Effect size




Expected variation (e.g. standard deviation)




An estimate of the expected difference between groups
Within-group variation

Where to get these?





Literature
Pilot study
Clinical experience
Minimal clinically-significant effect
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Sometimes you really don‟t know





What then?
“Convenience sample”
Should still justify the chosen sample size
With 2 of 3, can calculate the third (all else equal):




Sample size
Power
Effect size (maybe as a multiple of standard deviation)

Equivalence vs. superiority: sample size


Superiority trials are more efficient



Rule of thumb: allow 4x sample for equivalence trial as in
a corresponding superiority trial
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The caveat



With a superiority trial, a negative result (no stat-sig
difference) does not mean the treatments are equivalent!


Unless the 95% CI somehow managed to be within ±Δ anyway

Inclusion and exclusion criteria


Inclusion



Usually a shorter list
Who do you want?




Exclusion



Can be a longer list
Who do you not want?




Age ≥18, having surgery, planned nerve block, parturients, etc

E.g. LA allergy in a nerve block study, chronic pain, dementia,
prisoners, etc

Balance “clean” data vs. generalizability
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Arm allocation
Randomize. Usually

Benefits, etc


Helps mitigate systematic error








Learning effects
Staff changes
Seasonal variation in patient health
Weird stuff that nobody thought of
Etc.

When might it be inappropriate?



Investigating effect of a nonrandomizable demographic variable
Observational or retrospective studies
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What to do


Use a randomization service:





Conceal allocations until the last moment




random.org
randomization.com
E.g. sealed numbered envelopes

Blinding



Patient, provider to extent possible, assessor
Semiblinded data for analyst (e.g. group 1 vs group 2)

Examples of bad “randomization”



Coin toss by investigator
A – B –A – B –A – B






Etc., such as AAAA… BBBB…

Visible allocation list
Allocation bias is almost never deliberate, but it still
affects results
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Writing the protocol

What does a protocol do?


It describes the planned study




Justification, background
Goals
Methods









Sample
Outcomes
Logistics
Standards for observations
Analysis factors

It’s the cookbook
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Stuff to keep in mind


Balance of competing constraints









Logistics
Sample size
Consent
Randomization
Data-collection duration
Not a perfect world, and you don’t have infinite money
Circumstances vary. One study’s awesome approach may be
terrible in another

Logistics

Consent

Randomization

Sample
size

Data-collection
duration
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More stuff


Anticipate the criticism: what could be done better?



Think of some articles you’ve found to be less than convincing
What would happen if you made small changes?





Stay flexible during planning
Err on the side of simplification

What would this study look like under a different strategy:
observational, retrospective, prospective?



Can you still answer your research question?
Is another approach better, cheaper, faster, more awesome?

The protocol





Background
Hypotheses
Outcomes primary and secondary
Sample






Inclusion/exclusion criteria
Specific or general sample? Intended generalization
Power analysis

Stated standards for observations



Obviously needed for subjective data
Objective data: specified time points, methods for observation…
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Protocol, continued


Data management




How will it be kept? When will identifiers be removed?

Planned analyses and statistics





p threshold
Any interim analysis?
Be warned: any post-hoc analyses must be clearly labeled in the
poster/manuscript
We’re not discussing statistical techniques today

Keeping important people happy
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Regulatory stuff, etc


IRB





Clinicaltrials.gov




CITI, COI training
Consent language
Many journals require prospective registration of clinical trials

CONSORT diagram


Keep a count of exclusions/ consent refusals/ loss to followup

depts.washington.edu/hrtk/CSD/

CONSORT diagram
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Regulatory stuff, etc








IRB
Clinicaltrials.gov
CONSORT diagram
DSMB?
FDA?
Pre-Award?
VA?

It‟s not so scary
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Seriously – it‟s not


There is still lots of room for small studies



“In a given situation, should I do this, or should I do that?”



How would you know?
Now you’re halfway there

Recommended




“Bad Science” by Ben
Goldacre
BMJ “How to read a paper”
collection online
“How to Lie with Statistics”
by Darrell Huff (classic)
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This is the end
My only friend, the end
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